Analyst firms · BofA Securities · IONS
BofA Securities IONS price target and rating history
Ionis Pharmaceuticals Inc. (IONS) · Health Care
BofA Securities rates Ionis Pharmaceuticals Inc. (IONS) Buy with a $62 price target, as of its latest action on Jan 2, 2024. It has published 3 rating actions on IONS since February 2022, including 2 upgrades and 1 downgrade. Across 6 firms with a IONS price target in the last 12 months, the median target is $99.50.
- Current rating
- Buy
- Price target
- $62
- Median target, all firms
- $99.50
- Actions on IONS
- 3
BofA Securities price target on IONS
Every BofA Securities rating on IONS
- Jan 2, 2024
- Oct 23, 2023
- Feb 1, 2022
How other firms rate IONS
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| BMO Capital Markets | Outperform | $66 | Oct 22, 2026 |
| UBS | Buy | $88 | Oct 15, 2026 |
| Wolfe Research | Peer Perform | Jul 16, 2026 | |
| Citigroup | Buy | $115 | May 19, 2026 |
| Canaccord Genuity | Buy | $110 | Apr 21, 2026 |
| Raymond James | Outperform | $104 | Apr 10, 2026 |
| Barclays | Overweight | $95 | Jan 28, 2026 |
Questions about BofA Securities and IONS
- What is BofA Securities's price target for IONS?
- BofA Securities's latest stated price target for Ionis Pharmaceuticals Inc. (IONS) is $62, from its action on Jan 2, 2024.
- What is BofA Securities's rating on IONS?
- BofA Securities rates IONS Buy, a bullish rating, as of Jan 2, 2024.
- When did BofA Securities last change its view on IONS?
- On Jan 2, 2024, BofA Securities upgrades to Buy from Neutral, price target $52 to $62.
- How does BofA Securities's IONS target compare with other analysts?
- Across 6 firms with a IONS price target in the last 12 months, the median target is $99.50.
More IONS rating histories
All BofA Securities ratingsIONS news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.